Erlotinib
Erlotinib is a pharmaceutical raw material used in the manufacture of medications for certain cancers, primarily non-small cell lung cancer and pancreatic cancer. It functions as an active pharmaceutical ingredient targeting specific genetic mutations in the epidermal growth factor receptor.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 183321-74-6
Erlotinib hydrochloride
active pharmaceutical ingredient
3-Hydroxy Loratadine
antihistamine drug impurity
Abarelix
gonadotropin-releasing hormone antagonist
Befotertinib
active pharmaceutical ingredient
ETHACRIDINE LACTATE
active pharmaceutical ingredient
4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-Quinazolinol
Pharmaceutical intermediate
Neptinib
active pharmaceutical ingredient
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
active pharmaceutical ingredient
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
AAKJLRGGTJKAMG-UHFFFAOYSA-N
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC